Rigel Pharmaceuticals (RIGL) Current Deferred Revenue (2011 - 2025)
Rigel Pharmaceuticals' Current Deferred Revenue was $1.36 million in Q3 2025, unchanged from $1.36 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Current Deferred Revenue (2011 - 2025) Analysis & Trends
From Q2 2011 onward, Rigel Pharmaceuticals has reported Current Deferred Revenue for 35 quarters.
- Current Deferred Revenue shows a five-year compound annual growth rate of -44.3% (FY2019 to FY2024).
- In earlier years, Current Deferred Revenue was $1.36 million in FY2023 (-1.0%), $1.37 million in FY2022 (-47.3%), $2.6 million in FY2021 (-14.0%) and $3.02 million in FY2020 (-88.1%).
- Quarterly Current Deferred Revenue has moved between $1.36 million (Q2 2023) and $9.5 million (Q1 2021) over five years.
- The best year-over-year quarter for Current Deferred Revenue over five years was Q1 2021 (growth of 362.7%); the worst was Q4 2020 (a decline of 88.1%).
- Per Business Quant data, RIGL's Current Deferred Revenue in the three quarters before Q3 2025 was $1.36 million (Q2 2025), $1.36 million (Q1 2025) and $1.36 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Rigel Pharmaceuticals | 913.26 Mn | 379.15 Mn | 70.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 1.36 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.36 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 1.54 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 2.60 Mn |
| Sep 30, 2021 | 3.16 Mn |
| Jun 30, 2021 | 5.81 Mn |
| Mar 31, 2021 | 9.50 Mn |
| Dec 31, 2020 | 3.02 Mn |
API Access
Rigel Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();